Skip to main content
Decorative image of the AMR Learning Lounge

Clinical Advances in Diagnostic and Antimicrobial Stewardship 

SUMMARY

Medscape | 2024 

In today’s fight against multidrug-resistant organisms (MDROs), multiplex real-time polymerase chain reaction (PCR) testing platforms have proven to be a major advance over traditional culture-based tests.  

Improved diagnostic testing leads to more effective prescribing and the prevention of downstream antibiotic overuse. This growing collection of accredited continuing medical education (CME) activities — supported by an independent educational grant from bioMérieux — offers critical and timely information on the latest advances in syndromic PCR testing and its application in different clinical settings.  

 

GET STARTED

Find out more about Clinical Advances in Diagnostic and Antimicrobial Stewardship 

Access Now

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll
Global bioMérieux Solutions

GLOBAL Solutions

OPTIMIZE MY DIAGNOSTICS FOR ANTIMICROBIAL STEWARDSHIP

bioMérieux is committed to improving global public health and minimizing the impact of antimicrobial resistance. Our solutions enable an optimized use of antibiotics at each step of the antibiotic prescription workflow from patient admission to discharge. Listen to bioMérieux medical experts discuss the benefits of our end-to-end diagnostic offer. Our portfolio of diagnostic solutions, advanced analytics, consultancy services and educational modules will strengthen your stewardship initiatives.

Learn More
U.S. bioMérieux Solutions

US Solutions

OPTIMIZE MY DIAGNOSTICS FOR ANTIMICROBIAL STEWARDSHIP

Whether you are a healthcare professional or clinical laboratorian, our solutions can help you optimize use of diagnostics and data to enhance the continuum of care and slow the spread of antimicrobial resistance (AMR).

Learn More

PUBLISHED ON

August 2024

SHARE THIS ARTICLE: